Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia - Wikidata - wikimedia - TriplyDB

Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia

Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia

http://www.wikidata.org/entity/Q36989228

about

Can angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer's disease? An overview of research evidence in the elderly patient population Associations of centrally acting ACE inhibitors with cognitive decline and survival in Alzheimer's disease.Convergent evidences from human and animal studies implicate angiotensin I-converting enzyme activity in cognitive performance in schizophrenia.Comparing Approaches to Optimize Cut-off Scores for Short Cognitive Screening Instruments in Mild Cognitive Impairment and Dementia.Cognitive decline: mechanisms and proposed role of the renin-angiotensin-aldosterone system Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.Tolerability of Antihypertensive Medications in Older Adults.Elevated Plasma Aβ42 in Cognitively Impaired Individuals Taking ACE Inhibitor Antihypertensives.Comparative Effect of Lisinopril and Fosinopril in Mitigating Learning and Memory Deficit in Scopolamine-Induced Amnesic Rats.Association of cardiovascular system medications with cognitive function and dementia in older adults living in nursing homes in Australia.Inhibition of ACE Retards Tau Hyperphosphorylation and Signs of Neuronal Degeneration in Aged Rats Subjected to Chronic Mild Stress.How good are publicly available web services that predict bioactivity profiles for drug repurposing?Emotional function in dementia patients.Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer's disease.Challenges in the Management of Hypertension in Older Populations.

P2860

Q28077087-63026C22-4869-4482-B969-F8DE2B203836 Q33867559-B51BCF52-941E-4F7B-9B3B-DD5B2E55F7EC Q37347449-D0956B2C-46CC-4C46-B11A-54CD342A5ADB Q37693370-405241D3-474A-4A56-814B-CDEF7E60F83B Q38246323-E30CD4C4-D301-4062-9212-B3B46FCAA44E Q38259551-311266FA-8683-42D1-861B-D34899019B79 Q38600758-35BB1F45-B79A-47FB-8059-B8C381BD785E Q38690145-397910BF-18AA-4EB8-B441-0B248C67075E Q41860101-ACAAEE60-FC7E-4DB9-8D16-BF8648D1B932 Q42875420-85ED542A-2BFF-4912-A2B2-B8E2FC86CAF3 Q43132831-BAD75874-031F-4A92-91FD-F826002D6ADD Q45943515-C487E4B6-7322-46A5-9C65-0669AAD66861 Q47810336-D5436BE9-DB3A-423B-AA68-5369D99F640C Q48873920-DE9C1D4E-D83B-409A-B9A5-4CD2F0EB215C Q50101151-F27B739A-3550-4809-BAEF-2110A520E37C Q53555397-87081E14-AABC-409A-917B-00FEA6E6DC90

P2860

Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia

http://www.wikidata.org/entity/Q36989228

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia

@en

type

label

Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia

@en

prefLabel

Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia

@en

P1433

Q36989228-38542295-306E-4867-9A7C-F6B598F8CC1E

P1476

Q36989228-BEB2BB2F-E27B-4647-973E-937DEA8AFC5E

P2093

Q36989228-01011EEA-1008-4E3E-8444-1CB005345FDD

Q36989228-7ED6675A-4789-462C-B45D-AF2A6A6FF024

Q36989228-9E6A3C8B-F6B0-4574-A74E-8C86B6B674CB

Q36989228-D2B69EF7-51E9-42E6-8343-7E3ADFE5621A

Q36989228-EDBF4F45-4139-4DD7-B5A6-FB3CC3F7D10C

Q36989228-F47CF075-A348-4408-A7A2-D340BF28A2A3

P2860

Q36989228-038F2D95-67D4-4FD1-A563-877BD9F75816

Q36989228-04369F91-8F54-4A1F-B09B-525FED29E715

Q36989228-0FBD058F-725A-41DA-9239-BF13233DB60D

Q36989228-1465FA79-5B74-4101-AC24-719ABD1BD663

Q36989228-161AEE27-6291-466B-A583-CEE00E443008

Q36989228-175D652C-6B61-47FB-8AF4-46CA152FC278

Q36989228-1E8F36E4-048E-4AD0-9A2F-3E5BC44A13D3

Q36989228-2D0619BC-38C0-40EB-BDDE-73B165923327

Q36989228-2E7AC1A2-AF8B-47C1-BB05-5856E7F8E751

Q36989228-2EE0B35C-14FA-4B30-BA0D-56E11E299677

P31

Q36989228-44AFF875-4320-4668-B8AF-FC3B26305A95

P356

Q36989228-700C2880-260A-4747-8138-5A14485294B8

P433

Q36989228-39D75F79-A705-4DF7-94B1-4D615A10D487

P478

Q36989228-0A0B490F-27DB-4977-99E4-0E529B4AD806

P50

Q36989228-3E2EB5EC-9E4B-4122-B7E6-A5EBB360AAB4

Q36989228-B9C9B877-12D7-4E22-975B-1DFE856C2488

P577

Q36989228-7BA66803-4C5E-45FC-BDB7-69CF948E304B

P5875

Q36989228-64FF72E5-5BD1-4453-9AA5-A87EED7A047D

P698

Q36989228-15E8C570-E0BD-4401-85D6-8A54C886F098

P932

Q36989228-E3B63482-518D-489F-AF8E-736E7D82544C

P356

BMJOPEN-2013-002881

P1433

P1476

Effects of centrally acting ACE inhibitors on the rate of cognitive decline in dementia

@en

P2093

D William Molloy

http://www.w3.org/2001/XMLSchema#string

David M Kerins

http://www.w3.org/2001/XMLSchema#string

David Sammon

http://www.w3.org/2001/XMLSchema#string

Joseph Eustace

http://www.w3.org/2001/XMLSchema#string

Liam Healy

http://www.w3.org/2001/XMLSchema#string

Yang Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Global prevalence of dementia: a Delphi consensus study

Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis

Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease

Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

The Cardiovascular Health Study: design and rationale

The rationale and design of the antihypertensives and vascular, endothelial, and cognitive function (AVEC) trial in elderly hypertensives with early cognitive impairment: role of the renin angiotensin system inhibition.

Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta ); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity.

Antihypertensive agents and risk of Parkinson's disease, essential tremor and dementia: a population-based prospective study (NEDICES).

Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study

P31

scholarly article

P356

10.1136/BMJOPEN-2013-002881

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Rónán O'Caoimh

P577

2013-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

252324667

http://www.w3.org/2001/XMLSchema#string

P698

23887090

http://www.w3.org/2001/XMLSchema#string

P932

3703568

http://www.w3.org/2001/XMLSchema#string